Brought to you by 
Amneal grosses $854mm in private placement
18 Oct 2017
Executive Summary
Amneal Pharmaceuticals LLC (through Amneal Holdings) entered into definitive purchase agreements with institutional investors TPG and Fidelity Management & Research to gross $854mm through a private placement financing. The company plans to sell 46.8mm unregistered common shares at $18.25. The funding is concurrent with the merger the company has entered into with Impax Laboratories Inc.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
-
Drug Delivery
- Macromolecule
- Topical Delivery
- Transdermal
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Amneal grosses $854mm in private placement
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice